| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥230.1B | ¥262.3B | -12.3% |
| Operating Income | ¥7.8B | ¥10.0B | -21.7% |
| Ordinary Income | ¥7.8B | ¥9.9B | -20.8% |
| Net Income | ¥5.1B | ¥5.8B | -11.4% |
| ROE | 4.2% | 4.9% | - |
FY2026 Q3 cumulative results showed revenue of 230.1B yen (YoY -12.3%), operating income of 7.8B yen (YoY -21.7%), ordinary income of 7.8B yen (YoY -20.8%), and net income of 5.1B yen (YoY -11.4%). The company experienced both revenue decline and profit margin compression, with operating margin deteriorating to 3.4% from 3.8% in the prior year. Gross profit margin stood at 12.9%, reflecting persistent pressure on product profitability. The revenue-down/profit-down pattern continued, driven primarily by volume decline in the Selling segment and margin contraction in both segments.
Revenue declined 32.2B yen YoY (-12.3%), primarily driven by a 32.5B yen decrease (-12.5%) in the Selling segment, partially offset by a 0.4B yen increase (+1.1%) in Commissioned Manufacturing. The Selling segment, which accounts for 86.8% of total revenue, faced significant demand headwinds. Cost of sales decreased 27.1B yen to 200.5B yen, but the decline was insufficient to maintain margins, resulting in gross profit falling 5.1B yen to 29.7B yen with gross margin contracting to 12.9% from 13.2%. SG&A expenses decreased only modestly by 2.9B yen to 21.8B yen, representing 9.5% of revenue versus 9.4% prior year, indicating limited operating leverage. The segment notes reveal that inter-segment transactions increased, with Commissioned Manufacturing internal sales rising from 1.30B yen to 1.34B yen, suggesting some internal demand shift. Operating income declined 2.2B yen (-21.7%) to 7.8B yen due to the combination of lower sales volume and inadequate cost absorption. Non-operating items showed net expense of 0.1B yen, comprising dividend income of 0.2B yen offset by interest expense of 0.4B yen, resulting in ordinary income of 7.8B yen (-20.8% YoY). Income tax expense of 2.7B yen (effective tax rate 34.6%) led to net income of 5.1B yen. The gap between ordinary and net income of 2.7B yen is within normal range and primarily reflects tax burden. No extraordinary impairments or restructuring charges were reported. This represents a revenue-down/profit-down performance pattern, with profitability declining at a faster rate than revenue due to operational deleverage.
The Selling segment generated revenue of 199.9B yen with operating income of 3.1B yen, representing an operating margin of 1.5%. This segment, which constitutes the core business at 86.8% of total revenue, experienced the most significant pressure with YoY revenue decline and a thin margin profile. The Commissioned Manufacturing segment produced revenue of 46.8B yen with operating income of 3.5B yen, achieving a substantially higher operating margin of 7.5%. Despite being smaller in scale, this segment delivered 52.9% of total segment operating income, highlighting its superior profitability profile. The margin differential of 6.0 percentage points between segments is material and suggests the Commissioned Manufacturing business operates with better pricing power and cost structure. Internal sales within Commissioned Manufacturing rose to 1.34B yen from 1.30B yen, indicating some integration between segments. The segment profit adjustment of 123M yen represents elimination of inter-segment transactions and unallocated corporate expenses. The deterioration in overall profitability stems primarily from the volume decline in the lower-margin Selling segment combined with modest margin compression in Commissioned Manufacturing from 12.7% to 7.5%.
[Profitability] ROE of 4.2% reflects weak return on equity, decomposing into net profit margin of 2.2%, asset turnover of 0.96x, and financial leverage of 1.95x. Operating margin of 3.4% indicates limited operating efficiency, while gross margin of 12.9% suggests persistent product-level profitability challenges. Interest coverage ratio of 19.98x demonstrates adequate debt service capacity despite modest profitability. [Cash Quality] Cash and deposits of 86.1B yen provide substantial liquidity buffer, representing 1.08x coverage of current liabilities. Working capital efficiency shows mixed signals with inventory declining 28.2% YoY to 15.9B yen (positive for cash conversion) but receivables collection extending to approximately 72 days. [Investment Efficiency] Asset turnover of 0.96x falls below the 1.0x threshold, indicating suboptimal asset utilization. Property, plant and equipment of 59.7B yen represents 25.0% of total assets. Investment securities increased 34.4% to 8.7B yen, suggesting capital allocation toward financial assets. [Financial Health] Equity ratio of 51.2% provides solid financial foundation, well above concerning levels. Current ratio of 202.4% and quick ratio of 182.5% indicate strong short-term liquidity. Debt-to-equity ratio of 0.21x reflects conservative leverage with total long-term debt of 25.1B yen.
Cash and deposits increased 0.9B yen YoY to 86.1B yen despite operating profit decline, suggesting cash generation from working capital improvements. The significant inventory reduction of 6.3B yen (from 22.1B yen to 15.9B yen, -28.2% YoY) represents a major source of operating cash inflow, reflecting either demand-driven destocking or proactive inventory management. Trade receivables decreased 3.5B yen to 45.1B yen, contributing additional operating cash generation, though the implied DSO of approximately 72 days remains elevated. Trade payables decreased 5.1B yen to 28.2B yen, representing cash outflow that partially offset the working capital improvements. The net defined benefit liability increased 0.6B yen to 9.9B yen, suggesting pension funding requirements absorbed some cash. Investment securities grew 2.2B yen to 8.7B yen, indicating deployment of excess cash into financial assets. Long-term loans decreased 1.4B yen from 26.5B yen to 25.1B yen, reflecting scheduled debt repayment of approximately 1.4B yen. Retained earnings increased 1.7B yen from 76.6B yen to 78.3B yen, consistent with net income of 5.1B yen net of estimated dividends of 3.5B yen. The overall cash position stability despite revenue decline indicates the company successfully converted working capital reductions into liquidity, though sustainability depends on whether inventory reduction was strategic or demand-driven.
Ordinary income of 7.8B yen closely matched operating income of 7.8B yen, indicating minimal contribution from non-operating activities with net non-operating expense of approximately 0.1B yen. Non-operating income consisted primarily of dividend income of 0.2B yen from investment securities holdings, with minor other non-operating income of 0.1B yen totaling 0.4B yen. Non-operating expenses included interest expense of 0.4B yen on borrowings and negligible commission fees, totaling 0.5B yen. The non-operating net burden represents 0.04% of revenue, indicating core operations drive earnings. Extraordinary items were minimal with gain on sale of securities of 0.1B yen, representing non-recurring income that did not materially impact results. Comprehensive income of 6.6B yen exceeded net income of 5.1B yen by 1.5B yen, driven primarily by valuation gains on investment securities of 1.5B yen, reflecting unrealized market appreciation. The convergence of operating and ordinary income confirms earnings are predominantly operating-driven without artificial enhancement from financial activities. The absence of cash flow statement data limits assessment of operating cash flow versus net income, though the substantial working capital reduction (particularly 6.3B yen inventory decrease) suggests cash conversion likely exceeded reported profits, indicating healthy earnings quality from an accruals perspective.
Full-year guidance projects revenue of 295.0B yen (YoY -16.5%), operating income of 8.1B yen (YoY -47.8%), and ordinary income of 7.8B yen (YoY -48.9%). Q3 cumulative results show revenue progress of 78.0% and operating income progress of 96.9% against full-year targets, both tracking ahead of the normal 75% threshold for Q3. The advanced progress rate suggests the company may achieve or exceed current guidance, assuming Q4 performance remains stable. However, the full-year guidance implies significant operating income deterioration compared to the prior fiscal year, with operating margin expected to decline to 2.7% from prior year levels. No forecast revisions were announced this quarter, indicating management maintains its cautious outlook. The projected EPS of 108.61 yen compares to Q3 cumulative actual EPS of 147.05 yen (annualized basis approximately 196.07 yen if Q4 matches Q3 run-rate), suggesting either conservative guidance or anticipated Q4 weakness. The guidance assumes continued pressure on both revenue and margins, with profit declining at a faster rate than sales. The forecast notes indicate projections are based on currently available information and reasonable assumptions, with actual results subject to variation due to multiple factors.
The company forecasts an annual dividend of 100.00 yen per share for the full year. Based on Q3 cumulative net income of 5.1B yen and average shares outstanding of 3,499K shares, the implied dividend payout ratio calculates to approximately 69.1% (assuming full-year dividend of 100 yen × 3,499K shares ÷ projected full-year earnings). This represents a high payout ratio relative to earnings, suggesting strong shareholder return commitment. No interim dividend was paid, with the full 100 yen scheduled for year-end distribution. Comparing to prior year data is not available in the current dataset, limiting YoY dividend trend assessment. No share buyback programs were disclosed in the current period. The dividend yield can be estimated once share price data is available. The elevated payout ratio above 60% warrants monitoring for sustainability, particularly given declining earnings trends. However, the substantial cash position of 86.1B yen and strong current ratio of 202.4% provide near-term capacity to support dividends even if profits remain pressured.
Revenue concentration in the Selling segment, which accounts for 86.8% of total revenue with only 1.5% operating margin, creates vulnerability to demand fluctuations and pricing pressure in this core business. The segment's thin margin profile leaves limited buffer to absorb cost increases or volume declines. Deteriorating receivables turnover with DSO extending to approximately 72 days, well above the industry benchmark of 79 days median but approaching concerning levels, increases working capital requirements and potential bad debt exposure. Extended collection periods may signal customer financial stress or weakening negotiating position. Margin compression dynamics with operating margin declining to 3.4% and gross margin of 12.9% both below industry competitive levels suggest structural profitability challenges including pricing pressure, unfavorable product mix, or cost structure inefficiency. The company's low operating margin leaves minimal cushion for further adverse developments and limits reinvestment capacity for growth initiatives.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE 4.2% substantially underperforms the industry median of 6.4% (2025-Q3, n=19), placing the company in the lower quartile. Operating margin of 3.4% aligns with industry median of 3.2% (IQR: 1.7%-4.9%, n=17), while net profit margin of 2.2% falls below the industry median of 2.7% (IQR: 1.3%-6.0%, n=19), indicating below-median conversion from operating to net income.
Financial Health: Equity ratio of 51.2% exceeds the industry median of 46.4% (IQR: 39.6%-52.6%, n=19), reflecting conservative capital structure. Current ratio of 202.4% significantly outperforms the industry median of 188.0% (IQR: 164%-238%, n=15), demonstrating superior short-term liquidity.
Efficiency: Asset turnover of 0.96x falls slightly below the industry median of 1.00x (IQR: 0.62-1.20, n=19), suggesting modest room for improvement in asset utilization. Receivables turnover of approximately 72 days performs better than the industry median of 79 days (IQR: 67-103 days, n=18), though still elevated. Inventory turnover improved significantly with the 28.2% YoY reduction, though absolute days should be monitored against the industry median of 56 days (IQR: 42-84 days, n=17).
Growth: Revenue decline of 12.3% YoY substantially underperforms the industry median growth of 5.0% (IQR: -5.0% to +7.8%, n=19), placing the company among the weakest performers. EPS decline of 11.4% also lags the industry median EPS growth of 24% (IQR: 0%-107%, n=19).
Leverage: Financial leverage of 1.95x positions below the industry median of 2.13x (IQR: 1.87-2.46, n=19), consistent with the company's conservative debt profile and high equity ratio.
※ Industry: Trading (19 companies), Comparison: 2025-Q3 fiscal periods, Source: Proprietary analysis
Strong liquidity position with 86.1B yen cash and 202.4% current ratio significantly exceeding industry norms provides financial flexibility and downside protection, enabling the company to sustain operations and dividends through the current performance downturn while maintaining capacity for strategic investments or opportunistic acquisitions. Structural profitability challenges evidenced by ROE of 4.2% (well below 6.4% industry median), operating margin of 3.4%, and gross margin of only 12.9% indicate fundamental business model issues requiring operational restructuring, with the low-margin Selling segment (1.5% margin) representing 86.8% of revenue creating inherent earnings vulnerability that cannot be offset solely by the higher-margin Commissioned Manufacturing business. Aggressive working capital management demonstrated by 28.2% inventory reduction and improved receivables collection converted 9.8B yen of working capital into cash during a revenue decline period, suggesting management is actively optimizing the balance sheet, though sustainability depends on whether inventory reduction was strategic rationalization or demand-driven destocking that could constrain future sales capacity.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.